Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Vanguard Total Stock Market Index Fund ETF (VTI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Vanguard Total Stock Market Index Fund ETF — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while Vanguard Total Stock Market Index Fund ETF trades at $376.06 (market cap $2.30T). The key difference: Vanguard Total Stock Market Index Fund ETF is far larger — about 259× Kymera Therapeutics Inc. Common Stock's market cap, and Vanguard Total Stock Market Index Fund ETF is trading nearer its 52-week high, Kymera Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Vanguard Total Stock Market Index Fund ETF for 132 Days on average.
| KYMR | VTI | |
|---|---|---|
Market Cap | $8.88B | $2.30T |
Volume | 1,028,790 | 3,256,421 |
Sector | Health | — |
52-Week High | $127.31 | $384.30 |
52-Week Low | $55.80 | $311.68 |
Typical Hold Time | 0 Days | 132 Days |
Enterprise Value | $8.27B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VTI trades at $381.32, down slightly by 0.07% today, with strong technical momentum as moving averages signal bullish conditions. The ETF maintains broad U.S. equity exposure across 3,500+ stocks, though concentration in top holdings remains a diversification consideration. Recent dividend activity and positive media coverage highlight its role in long-term portfolios.
Outlook remains favorable for buy-and-hold investors seeking diversified U.S. market exposure, with risks including market concentration and economic sensitivity. Technical strength supports near-term upside, while fundamental breadth provides stability across market cycles.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Vanguard Total Stock Market Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the index, which represents approximately 100% of the investable US stock market and includes large-, mid-, small-, and micro-cap stocks. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.
Read more on VTI →
